§ Claim under review · Study
"In a newly identified Sardinian mountain village blue zone, women who reach age 70 are three times as likely to reach 100 as their U.S. counterparts." (Post caption: "Women in this Sardinian mountain village have high odds of living to 100. Researchers have identified it as a new blue zone... Here, women who reach 70 are three times as likely to reach the century mark as their U.S. counterparts.")
Verdict
Mostly accurate
Confidence
HighSummary
This one is largely accurate. A real peer-reviewed study published in Frontiers in Aging on October 5, 2026 found that women in the Sardinian village of Bolotana who reach age 70 have an estimated 13.8 percent chance of reaching 100, compared with about 3.6 percent for women in the United States. That is roughly a 3.8 times difference, so the post's "three times" figure is if anything conservative, and the post correctly notes the finding applies only to women who have already reached 70. The main overstatement is the word "newly identified." The researchers call Bolotana a candidate blue zone and say explicitly that longer observation is needed before it counts as an established one. Two things the post leaves out: the estimate has a wide margin of error, from about 7 percent to about 24 percent, and the preceding five-year period showed a much weaker result, so it is not yet clear whether this is a lasting pattern. The study also did not test why these women live so long, and National Geographic is reporting on a project it helped lead rather than on independent research.
The readings
key figures from the evidenceconditional survival from age 70 to 100, Bolotana women
conditional survival from 70 to 100, U.S. women
95% confidence interval for Bolotana women's survival estimate
Why this verdict
Evidence
The specific statistic in the post traces directly to a real, peer-reviewed study and matches it. The study constructed sex-specific period life tables for 2021 to 2025 using validated civil and parish records, defining late-life survival as survival from age 70 onward and measuring remaining life expectancy at age 70 and conditional survival from age 70 to 100 . Conditional survival from 70 to 100 was 4.92% (95% CI 1.58 to 12.76) in men and 13.83% (7.33 to 23.75) in women; among international benchmarks Bolotana women ranked second only to Hong Kong on both indicators, and survival to 100 was more than three times that of U.S. women .
The comparison figure is roughly 3.6% for U.S. women. The study estimates that 13.8% of women in Bolotana who reach 70 will survive to 100, versus approximately 3.6% of U.S. women, roughly one in seven compared with one in 28 . That ratio is actually about 3.8 to 1, so "three times" is a conservative rounding, not an exaggeration.
The village's centenarian concentration and the age-verification work are also documented. In 2024, six people aged 100 or older lived in the village, a prevalence roughly 11 times higher than the United States, and the team matched birth, death and baptismal records to validate centenarian ages . Researchers found civil birth documents for every identified centenarian and verified 97% of recorded centenarian deaths against separate church records; among 3,060 people born in Bolotana between 1900 and 1925, 38 were documented as living to at least 100 .
Findings
✓ What's accurate 6
- The study exists, is peer reviewed, is published in Frontiers in Aging, and was released the same day as the post.
- The "three times" figure is real, matches the published abstract, and if anything understates the point estimate (13.8% versus 3.6% is about 3.8 times).
- The framing "women who reach age 70" correctly reflects the study's conditional-survival design. This is not a general life expectancy claim, and the post states the age-70 condition accurately.
- The location description, a Sardinian mountain village, is accurate for Bolotana.
- The post's caption correctly characterizes the blue zone definition used by this research team: residents aged 70 and older with exceptional survival.
- The caption's statement that researchers are investigating diet, family life and genetics, rather than claiming these are proven causes, is accurate and appropriately hedged.
≈ What's misleading 4
- Omitted qualifier, status: the post says researchers "have identified it as a new blue zone." The study title ends in a question mark and the conclusion says it "may be considered a candidate" blue zone, explicitly requiring longer observation before established status. Even the Blue Zones organization's own press release uses the word "candidate" in its headline. The post converts a provisional designation into a completed one.
- Omitted qualifier, uncertainty: the point estimate of 13.83% has a confidence interval of 7.33% to 23.75%. The "three times" multiplier is presented as a fixed fact when the underlying estimate is statistically fragile due to small numbers of deaths at extreme ages.
- Temporal narrowing: the finding rests on a single five-year window, 2021 to 2025. The immediately preceding five-year window showed a substantially weaker profile. The post gives no sense that the result is period-specific.
- Potential reader inference: describing this as a place where women "have high odds of living to 100" may lead readers to treat a relative advantage as a high absolute probability. The absolute figure is about one in seven, meaning roughly six in seven women who reach 70 there still do not reach 100.
? What's uncertain 4
- Whether the 2021 to 2025 advantage is a durable pattern or a short-run fluctuation in a village of about 2,300 people. The authors themselves flag this as unresolved.
- Any causal explanation. Diet, genetics, social structure and healthcare access are named as hypotheses only, and were not tested.
- Whether Bolotana will be formally accepted as a blue zone by the wider demographic community. Blue zone methodology has drawn prior criticism over record quality, though this study's age-validation is unusually strong on that specific point.
- I could not retrieve the full international benchmark table directly, so the precise U.S. comparison value (reported variously as 3.5% and 3.6%) and its source period are taken from the institutional press release and secondary coverage rather than read from the paper's table.
Sources
4 of 5 linked to recordsAustad, Beltrán-Sánchez, Buettner, Olshansky, Pedde, Pes, Romerio, "A new blue zone? Exceptional late-life survival in Bolotana, Sardinia," Frontiers in Aging, DOI 10.3389/fragi.2026.1951042
University of Illinois Chicago press release / EurekAlert
Blue Zones LLC press release (study sponsor/project leader's organization)
National Geographic article underlying the Instagram post
MedicalXpress, Discover, Earth.com, Medical Daily, Il Sole 24 Ore, Yahoo/Telegraph